A currency trader watches monitors at the foreign exchange dealing room of the KEB Hana Bank headquarters in Seoul, South Korea, Friday, Nov. 20, 2020. Asian shares mostly rose in muted trading Friday after Wall Street eked out modest gains amid a tug of war between worries about the worsening pandemic in the present and optimism that a vaccine will rescue the economy in the future. (AP Photo/Ahn Young-joon)
Currency traders watch monitors at the foreign exchange dealing room of the KEB Hana Bank headquarters in Seoul, South Korea, Friday, Nov. 20, 2020. Asian shares mostly rose in muted trading Friday after Wall Street eked out modest gains amid a tug of war between worries about the worsening pandemic in the present and optimism that a vaccine will rescue the economy in the future. (AP Photo/Ahn Young-joon)
Currency traders work at the foreign exchange dealing room of the KEB Hana Bank headquarters in Seoul, South Korea, Friday, Nov. 20, 2020. Asian shares mostly rose in muted trading Friday after Wall Street eked out modest gains amid a tug of war between worries about the worsening pandemic in the present and optimism that a vaccine will rescue the economy in the future. (AP Photo/Ahn Young-joon)
A currency trader passes by screens showing the Korea Composite Stock Price Index (KOSPI), center, and the exchange rate of South Korean won against the U.S. dollar, right, at the foreign exchange dealing room of the KEB Hana Bank headquarters in Seoul, South Korea, Friday, Nov. 20, 2020. Asian shares mostly rose in muted trading Friday after Wall Street eked out modest gains amid a tug of war between worries about the worsening pandemic in the present and optimism that a vaccine will rescue the economy in the future. (AP Photo/Ahn Young-joon)
TOKYO (AP) — Global shares were mixed in muted trading Friday amid a continuing conflict between current worries over the worsening pandemic and optimism that vaccines will rescue the economy in the future.
France's CAC 40 rose 0.2% in early trading to 5,487.73, while Germany's DAX dipped slightly to 13,085.18. Britain's FTSE 100 gained nearly 0.3% to 6,351.14. U.S. shares were set to drift lower with Dow futures falling 0.5% to 29,295. S&P 500 futures were down 0.4% at 3,565.88.
Japan's benchmark Nikkei 225 slipped 0.4% to finish at 25,527.37. Australia's S&P/ASX 200 edged down 0.1% to 6,539.20. South Korea's Kospi added 0.2% to 2,553.50. Hong Kong's Hang Seng gained 0.4% to 26,451.54, while the Shanghai Composite rose 0.4% to 3,377.73.
Investors were looking ahead to data that will be out next week on the health of regional economies, including India, which has been hit hard by the pandemic, and also Taiwan and Singapore.
“The focus next week in Asia will be the extent of India’s bounce back in the third quarter, as the data in October underscores the renewed threat to the region from the second wave of the pandemic,” said Prakash Sakpal, senior economist Asia at ING.
Japan, which is heading into a three-day weekend, has had its optimism dashed by record daily COVID-19 cases. Although Japan has had fewer deaths related to the pandemic — under 2,000 — compared to harder-hit nations, worries are growing about a need for stricter restrictions on travel and anti-infection measures.
Wall Street’s huge November rally has slowed this week as fears about the economy buckling in the near term collide with hopes that stronger growth will arrive next year once effective coronavirus vaccines become available.
With infections and hospitalizations on the rise across much of the country, governors and mayors are grudgingly issuing mask mandates, limiting the size of gatherings, banning indoor restaurant dining, closing gyms and restricting the hours and capacity of other businesses.
Democrats and Republicans in Washington are still stymied in their attempts to deliver another dose of financial support to workers and businesses. That has the specter of a bleak winter looming for both the health care system and the economy.
Counterbalancing all those fears is hope that coming vaccines can control the pandemic and get the global economy back toward normal next year.
“The market is grappling with the push and pull of the progress with the vaccine track, which allows a window to when our economy can reopen, with the current reality of rising cases,” said Bill Northey, senior investment director at U.S. Bank Wealth Management.
University of Oxford scientists expect to report results from the late-stage trials of the COVID-19 vaccine they're developing with AstraZeneca by Christmas, according to a researcher. Already this month, pharmaceutical companies have offered data suggesting other vaccines under development could be highly effective. Pfizer and BioNTech have said they plan to ask U.S. regulators within days to allow emergency use of their vaccine.
In energy trading, benchmark U.S. crude fell 13 cents to $41.61 a barrel. Brent crude, the international standard, rose 4 cents to $44.24 a barrel.
In currency trading, the dollar inched down to 103.88 Japanese yen from 103.98 yen. The euro cost $1.1871, up from $1.1834.
___
AP Business Writers Stan Choe, Damian J. Troise and Alex Veiga contributed.
Companies Mentioned in This Article
Compare These Stocks Add These Stocks to My Watchlist 7 Stocks to Own For the Next Decade
According to Blackrock (NYSE:BLK) analysts, investors looking for growth as the economy begins to recover need to be in stocks. In fact, many investors are breathing a sigh of relief for not panicking when the market sold off in February and March.
But while a Black Swan event like the Covid-19 pandemic can teach investors short-term lessons, the trick to buy-and-hold investing is identifying companies that give you the confidence to invest for not just 10 weeks but 10 years.
For many investors, this means identifying key trends. Before the pandemic, trends were emerging. Those trends, such as e-commerce, financial technology, digital healthcare, are quickly becoming part of our “new normal.” Think about it. Cash is now literally “dirty money.” E-commerce is not just convenient; it’s essential. And we’ve figured out that the patient-doctor relationship can take place via video chat.
And all of this feeds into other trends, including the idea that our smartphones are only going to become more powerful and more important. But the next 10 years are not destined to be the decade of stealth small-caps. Many of the companies that are well-positioned for the next decade will be familiar to most investors.
Here are 7 companies that are going to become increasingly relevant over the next decade. When you buy them now, you’ll be thanking yourself when the calendar turns to 2030.
View the "7 Stocks to Own For the Next Decade".
